European Regulation Affecting Nanomaterials - Review of Limitations and Future Recommendations

After learning about the potential risks associated with various specific nanomaterials, concerns have been raised about adequacy of existing regulation in Europe and what should be done to address any potential regulatory gaps related to nanomaterials. Understanding the limitations of the current regulation in regard to nanomaterials is a starting point in a democratic and transparent process towards adapting existing laws and facilitating an informed discussion about which kind of regulatory options best address the identified limitations. In the following we will introduce key pieces of European legislation affecting nanomaterials, analyze their limitations, and provide a number of recommendations on how these can be overcome. We find that, although nanomaterials are in principle covered by the scope of many of the existing legislative frameworks, it is often unclear, if current regulations are actually applicable when it comes to specific nanomaterials and their diverse applications. Main limitations seem to be: that requirements to do safety evaluations are triggered by production volumes by tonnage not tailored to the nanoscale, the profound lack of (eco)toxicological data, and that thresholds values and occupational exposure limits cannot be established with existing methodologies.

[1]  Richard D. Handy,et al.  The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs , 2008, Ecotoxicology.

[2]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[3]  M. Marinovich,et al.  Risk Assessment of Products of Nanotechnologies , 2009 .

[4]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[5]  Holger Schulz,et al.  Inflammatory Response to TiO2 and Carbonaceous Particles Scales Best with BET Surface Area , 2007, Environmental health perspectives.

[6]  Steffen Foss Hansen,et al.  Categorization framework to aid hazard identification of nanomaterials , 2007 .

[7]  Steffen Foss Hansen,et al.  Environmental challenges for nanomedicine. , 2008, Nanomedicine.

[8]  Nanna B. Hartmann,et al.  Ecotoxicity of engineered nanoparticles to aquatic invertebrates: a brief review and recommendations for future toxicity testing , 2008, Ecotoxicology.

[9]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[10]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[11]  K. Wittmaack In Search of the Most Relevant Parameter for Quantifying Lung Inflammatory Response to Nanoparticle Exposure: Particle Number, Surface Area, or What? , 2006, Environmental health perspectives.

[12]  Herbert White,et al.  Community code relating to medicinal products for human use , 2014 .

[13]  J. Heyder,et al.  Instillation of Six Different Ultrafine Carbon Particles Indicates a Surface Area Threshold Dose for Acute Lung Inflammation in Mice , 2005, Environmental health perspectives.

[14]  Steffen Foss Hansen,et al.  Regulation and Risk Assessment of Nanomaterials - Too Little, Too Late? , 2009 .

[15]  S. Olsen,et al.  Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials. , 2007, Regulatory toxicology and pharmacology : RTP.

[16]  Laura Hodson,et al.  Approaches to safe nanotechnology; managing the health and safety concerns associated with engineered nanomaterials , 2009 .

[17]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  P. Swuste,et al.  Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. , 2008, The Annals of occupational hygiene.

[19]  Steffi Friedrichs,et al.  Nanomaterials and regulation of cosmetics. , 2010, Nature nanotechnology.

[20]  F. Cataldo A STUDY ON THE THERMAL STABILITY TO 1000°C OF VARIOUS CARBON ALLOTROPES AND CARBONACEOUS MATTER BOTH UNDER NITROGEN AND IN AIR , 2002 .

[21]  David B Warheit,et al.  Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  T. Webb,et al.  Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. , 2007, Toxicology.

[23]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[24]  John C Crittenden,et al.  Enhanced bioaccumulation of cadmium in carp in the presence of titanium dioxide nanoparticles. , 2007, Chemosphere.

[25]  Nanna B. Hartmann,et al.  Ecotoxicity of engineered nanoparticles to freshwater organisms , 2011 .

[26]  Christian Micheletti,et al.  Engineered nanoparticles: Review of health and environmental safety (ENRHES). Project Final Report , 2010 .

[27]  G. Oberdörster,et al.  Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles , 1996 .